Tuesday, October 27, 2015 12:14:22 PM
here understand the dilution problem with the share structure.
It's not a big problem though compared to the majority of other
pinks out there 'with' verifiable product sales since BIEL has
excellent market saturation (years) backed up by studies done
by professional businesses hired by Bioelectronics as well as
consumers (all documented, readying for FDA clearence) Your P/E
ratio sounds about right but if you consider other future vendors
that have ad space available BIEL could take advantage of, this P/E
number could drastically change literally overnight. Let's say BIEL signed a deal with both Microsoft, Apple, Gateway to show on their
online store with a front in their top items of choice viewed by
10s of millions of pc consumers who buy computers every year?
Sales or not, that P/E ratio would go into the stratosphere then
keep going north along with the share price. Plenty of options for BIEL profits here$$$$$
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM